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Abstract
Susceptibility to most human diseases is polygenic, with complex interactions between functional
polymorphisms of single genes governing disease incidence, phenotype, or both. In this context, the
contribution of any discrete gene is generally modest for a single individual, but may confer
substantial attributable risk on a population level. Environmental exposure can modify the effects of
a polymorphism, either by providing a necessary substrate for development of human disease or
because the effects of a given exposure modulate the effects of the gene. In several diseases, genetic
polymorphisms have been shown to be context-dependent, i.e. the effects of a genetic variant are
realized only in the setting of a relevant exposure. Since sarcoidosis susceptibility is dependent on
both genetic and environmental modifiers, the study of gene-environment interactions may yield
important pathogenetic information and will likely be crucial for uncovering the range of genetic
susceptibility loci. However, the complexity of these relationships implies that investigations of gene-
environment interactions will require the study of large cohorts with carefully-defined exposures and
similar clinical phenotypes. A general principle is that the study of gene-environment interactions
requires a sample size at least several-fold greater than for either factor alone. To date, the presence
of environmental modifiers has been demonstrated for one sarcoidosis susceptibility locus, HLA-
DQB1, in African-American families. This article reviews general considerations obtaining for the
study of gene-environment interactions in sarcoidosis. It also describes the limited current
understanding of the role of environmental influences on sarcoidosis susceptibility genes.
Introduction
Sarcoidosis is a systemic inflammatory syndrome of unknown etiology characterized by
accumulation of immune effector cells in affected organs [1]. Noncaseating granulomas are
the pathologic hallmark of the disease, and the clinical course is extremely heterogeneous.
There are accumulating parallel data suggesting important roles for both genetic susceptibility
(reviewed by DuBois) and specific transmissible environmental agents (reviewed by Crouser)
(Table 1). A variety of investigators have reported important susceptibility and protective roles
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for genes mediating immune responses, especially for the human leukocyte antigen (HLA)
genes located on Chromosome 6p [2-4]. The HLA genes govern the expression of the Type II
major histocompatibility complex (MHC) on antigen presenting cells, which mediates antigen-
specific responses to exogenous agents by presenting the relevant antigen to a cognate T-cell
antigen receptor that is expressed on the surface of T-cells. These observations fit well with
the current concepts of disease pathogenesis, reserving a central role for activation of antigen-
specific oligoclonal CD4+ T-cells by MHC Class II-restricted antigen presenting cells, which
then amplify immune mechanisms that lead to granuloma formation. At the same time, there
are epidemiologic and experimental observations suggesting a causative role for several
environmental exposures, likely in the form of respirable particles. These two avenues of
investigation, genetic and environmental, support the general hypothesis that development of
sarcoidosis depends on an appropriate exposure in a genetically susceptible host (Figure 1).
Bridging the two approaches is a challenge for sarcoidosis research.
It is clear that there is not one set of genetic susceptibility markers that is sufficient to explain
all sarcoidosis cases. In this regard, numerous attempts to define disease susceptibility genes,
usually by candidate gene approaches, although more recently using haplotype analysis, have
yielded results that are poorly reproducible [5]. More recently, two whole genome scans have
yielded differing results, possibly because two different populations were studied [6,7]. Recent
successful genetic analyses have relied on defining very clear phenotypes, such as Lofgren’s
syndrome, to demonstrate reproducibility between populations [8,9]. These findings illuminate
the need for assiduous clinical phenotyping, careful study design and circumspection when
extrapolating results between groups. Likewise, the influence of variable environmental
exposures on the results of most genetic studies has not been tested.
Several exposures have been suggested to mediate disease risk, but there has also been poor
reproducibility of the findings, leading to the hypothesis that a range of agents may mediate
sarcoidosis, and that epidemiologic risk factors may vary between disparate populations. It is
possible that the correct term is “sarcoidoses”, connoting a set of stereotyped immune responses
to various agents that may display phenotypic differences and for which various pathogenetic
mechanisms might obtain. Therefore, dissecting the interactions between genetic
polymorphisms and environmental exposures will likely be highly relevant to advancing
understanding of pathogenesis. However, several considerations present obstacles to these
lines of investigation.
Gene-environment interactions
General considerations
Progress in genetic epidemiology and genotyping technology has yielded tremendous advances
in recent years. Useful information on disease pathogenesis, genetic susceptibility profiling,
and pharmacogenomics have been derived from these endeavors. In contrast, although it is
widely recognized that many human diseases are influenced by both genes and environment,
the study of gene-environment interactions is in its infancy. Many susceptibility genes do not
have a substantial primary etiologic role but rather modulate an individual’s response to
environmental cues—i.e. they function as response modifiers in an appropriate environmental
context [10]. The variants in complex genetic diseases such as sarcoidosis are usually relatively
common polymorphisms that might not result in overt recognizable phenotypes until the
appropriate conditions are available.
Defined broadly, as either additive or multiplicative interactions, gene-environment
interactions influence many familiar human diseases. Examples include breast cancer, asthma,
venous thrombosis, and dyslipidemia [11-15]. That these conditions are influenced by both
genes and environment implies a statistical, but not necessarily a biologic, interaction between
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the gene and the environmental factor. A statistical interaction implies that both the gene and
the environmental factor independently contribute main effects to the risk of developing
disease.
Statistical gene-environment relationships might be categorized by defining them as requisite
vs. modifier and additive vs. multiplicative [16,17]. All these relationships are likely to be
present in sarcoidosis, a complex human disease with multiple genetic and environmental
modifiers. A requisite relationship implies that the exposure (or gene) is a necessary causative
agent of disease or phenotype among individuals with the susceptibility gene (or exposure); in
a modifier relationship, the exposure or gene modifies the likelihood of disease susceptibility
or phenotype but is not the triggering etiology (Fig 3). The additive versus multiplicative term
refers to the mathematical effect of the relationship; additive modifiers are generally used to
describe the effects of continuous variables, while multiplicative terms more often are used for
stratified analyses [18]. Malignant melanoma is an example of a “requisite” gene-environment
relationship: incidence is influenced by the degree of ultraviolet exposure in carriers of a
mutation in a cell-cycle regulatory protein, CDKN2A [19]. Tobacco exposure and the risk of
granulomatous lung diseases represent a susceptibility modifier. For example, the development
of hypersensitivity pneumonitis due to avian antigens is more likely in pigeon breeders with
specific HLA-DR and DQ haplotypes [20]. However, individuals who smoke tobacco are
relatively protected from sensitization and this disease [21]. The phenotype of disease may
also be altered by environmental or genetic modifiers. For example, tobacco smoking increases
the risk of pulmonary metastases among breast cancer patients from 1.06-3.73 fold depending
on the cumulative dose [22]. Statistical gene-environment relationships can generally be
examined by conventional regression analysis and are not the focus of this review.
In a more narrow sense, a gene-environment interaction implies a relationship that influences
a disease phenotype more than would be expected from the additive or multiplicative
combination of the genetic and environmental components (Figure 2d). In other words, a true
interaction implies that there is a biologic relationship between the environmental exposure
and the gene. A hypothetical example is provided in Table 2. To date, relatively few gene-
environment interactions of this type have been described. An example of these types of gene-
environment interactions is illustrated by the effect of endothelin-1 on systolic blood pressure.
Tiret et al. studied the effect of a functional polymorphism that causes an amino acid change
(Lys? Asn) at codon 198 [10]. The presence of any Asn allele was more strongly associated
with systolic blood pressure at high body mass index, but the effect was absent or possibly
reversed in thin individuals (similar to Figure 2d). Similarly, it has been suggested that the
CD14 (LPS binding protein receptor) C159T promoter polymorphism may influence asthma
risk, but in opposite directions depending on the level of environmental endotoxin exposure
[13]. Uncovering these biologic gene-environment interactions for sarcoidosis will likely
require larger sample sizes and non-traditional statistical approaches to succeed broadly.
Fortunately, the general requirement for larger sample-sizes when evaluating interactions may
be mitigated in special circumstances, such as when the gene or the exposure is very rare.
Strategies to study gene-environment interaction
Study designs
As a general principle, exposure can be assessed using cohort, case-control, or family-based
designs. The strengths and weaknesses of these approaches for sarcoidosis are summarized in
Table 3. Population cohort studies have the advantages of minimizing selection bias,
ascertainment bias, and avoiding recall error when assessing exposures. However, in the case
of uncommon diseases with variable age of onset and unclear disease latency, cohort studies
are problematic [23]. To be effective in sarcoidosis research, very large groups would need to
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be recruited and periodically screened for disease. In addition, epidemiologic risk factors would
need to be prospectively identified and measured at the inception of the study.
Case-control studies are employed more commonly since they are less complex. When using
case-control designs, however, a major challenge is minimizing classification error for
environmental exposures [24]. Unlike genetic studies, where accuracy for common genotyping
methods typically exceeds 99%, accurate assessment of exposure in epidemiologic studies may
be less than 80% [24]. A number of factors influence the ability to define exposure—including
appreciation of threshold effects (e.g. the minimum dose to induce a gene), the pattern of dose-
response curve (e.g. logarithmic vs linear), and the latency from exposure to a gene-driven
response. Misclassification of individuals’ exposure, classification error, can be expressed as
a correlation coefficient between an observer and a reference standard (r=0.8 implies a 20%
error rate). The effects of even small classification errors are not trivial, as illustrated by the
example in Figure 4. For a theoretical exposure conferring a relative risk of 2.0, an assessment
tool that misclassified exposures in 20% of cases would estimate the risk as 1.7.
The implications of exposure misclassification errors include underestimates of actual risk,
failure to find true associations due to inadequate sample size, publication and funding bias
favoring gene-only studies (since genetic misclassification rates are substantially lower), and
poor reproducibility of genetic studies in instances where environmental factors truly do
interact with a polymorphism. For example, low ozone concentrations appear to be necessary
to develop the effects of the -308 TNF promoter polymorphism on asthma prevalence, perhaps
accounting for inconsistent results among prior studies of this gene [12]. Exposure
misclassification errors are magnified when intercalated into calculations of interactions with
genetic polymorphisms, since testing for interaction necessarily requires several fold-increases
in sample size [23].
Family-based designs are an attractive option for studying gene-environment interactions. A
major weakness of case-control studies, population stratification, can be avoided entirely by
using family-based designs. Population stratification refers to segregation of a candidate
susceptibility polymorphism differently in cases versus controls due to differences in ancestral
origin. For example, consider a situation where African-American case subjects from
Cleveland (predominantly West African origin) are compared with control subjects from
Columbus, Ohio, which has a substantial Sudanese population. If the population frequency of
genotype A in blacks of West African descent is 0.2, but it is 0.4 in individuals originating
from Sudan, the putative sarcoidosis “susceptibility gene” may actually be a marker of the
divergent genetic ancestry of the two populations. Population stratification may skew results
for interactions more than for independent effects of genes or environment, especially when
the interaction is strong [25].
In family-based designs, assuming consanguity, population stratification issues can be avoided
entirely. When the carriage of an allele is associated more strongly with risk of a trait than
predicted for Mendelian transmission among family members, then that locus may be
potentially associated with the trait or in linkage disequilibrium with a gene that confers risk
for the trait. Affected sibling pair methods are a subtype of family based study that rely on
similar assumptions, and can be accomplished without obtaining parental DNA. Family-based
designs may require a higher sample size than case-control studies for testing genetic main
effects due to overmatching, but when looking for gene-environment interactions,
overmatching is actually helpful, and reduces sample size requirements [26]. Family-based
designs are also attractive in sarcoidosis because of the presence of familial sarcoidosis, with
odds ratios for disease ranging from 3.8 to 5.8 among affected family members [27].
Weaknesses of family-based designs for studying gene-environment interactions include
difficulties obtaining sibling or parental control DNA and exposure histories, questions of
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consanguity, and statistical power for exposures that are not frequent. Also, these studies will
share the same recall biases that occur in case-control studies.
Modeling interactions
A general issue that complicates studies of gene-environment interaction is the need for much
larger sample sizes, especially when multiple or less common genes or exposures are tested.
One potential strategy may be to use parametric models incorporating pre-existing gene data
to support or refute specific hypotheses [23]. Candidate pathways or exposures can then be
investigated in detail, either as discrete variables or functional groups. For example, it may be
useful to examine environmental factors in relation to genes for which marginal effects on
disease have previously been estimated, or to use “case-only” designs [28]. This type of “two-
step” analysis risks underestimating gene-environment interactions in cases where the
interaction is strongly multiplicative, but may often be sufficient for additive relationships.
More complex modeling may be required to study the effects of multiple allelic variables, such
as haplotypes of linked single nucleotide polymorphisms (SNPs), or multiple environmental
exposures. In these circumstances, stratified models may fail to provide enough observations
for all but the most common gene-environment combinations [23].
A similar strategy, Mendelian randomization, is to use traditional genetic association studies
to define polymorphisms that inform “internal phenotypes” lying on the causal pathway
between the environmental exposure and the disease (Figure 5) [29,30]. For example, Davey
Smith and Ebrahim described the use of Mendelian randomization to assess the risk of
developing neural tube defects in relation to maternal folate ingestion. This association might
be difficult to prove in epidemiologic studies since multiple dietary and socioeconomic
confounders would complicate the analysis. However, the importance of the environmental
exposure (folate level) can be inferred by examining the trait risks associated with maternal
methylene tetrahydrofolate reductase polymorphisms and the functional effects of the
polymorphisms on folate levels [29]. This approach has the advantage of avoiding all the
problems of accurate diet assessment and socioeconomic confounders, since the presence of
the genetic polymorphisms is unlikely to be associated with these confounding variables. It
may also be useful for choosing among competing environmental factors when there are
multiple exposures; if a relevant gene can be linked to an intermediate phenotype, then the
importance of a specific exposure can be inferred. However, caution will still need to be used,
since population stratification, linkage disequilibrium, and inadequate sample size can all lead
to incorrect results.
A more recent example is for psoriasis, where this approach was used to suggest a role for non-
metabolized tobacco products as etiologic risk factors. Epidemiologic studies of psoriasis had
suggested a potential role for several environmental exposures, including tobacco
consumption, alcohol, infections and medications, however the results were anecdotal and
inconclusive. Richter-Hintz et al. conducted a case-control association study for a panel of
polymorphisms among xenobiotic metabolizing enzymes [31]. The results suggested that a
common (hypoactive) CYP1A1 variant conferred disease susceptibility. CYP1A1 is important
for metabolism of tobacco compounds, and in subsequent analysis, the at-risk genotype was
found to interact strongly with tobacco use, where it conferred risk more strongly in smokers
(O.R. 3.6, p=0.01) than ex-smokers (O.R. 2.88, p=0.04) or never-smokers (O.R. 1.6, p=0.18)
[32].
This approach can also be used to study the mechanism of gene-environment interactions. For
example, Padyukov et al. investigated smoking status and several HLA-DR alleles, called
shared epitope (SE) genes, in a population-based case-control study of rheumatoid arthritis
[33]. A strong gene-environment interaction was found for seropositive disease, with 40% of
incident seropositive cases attributable to the gene-environment interaction alone. The
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pathophysiology of the interaction was then elucidated by exploring the development of an
internal phenotype for rheumatoid arthritis—the presence of antibodies to citrullinated
proteins. Since citrullination of proteins increases the likelihood of binding with SE-containing
HLA-DR residues, this process may render self proteins more immunogenic. In this situation,
the shared epitope HLA genes can be associated with the development of antibodies to
citrullinated proteins, an internal phenotype that is driven by tobacco exposure in a dose
dependent manner [34]. The relationship between the susceptibility genes, development of
anticitrulline antibodies, and the presence of smoking is powerful enough to explain all the
findings of the initial association study [34].
For sarcoidosis, polymorphisms in several genes (NRAMP, TLR4, HLA, Vitamin D receptor)
involved in the immune response to exogenous pathogens have been investigated [1,35-37],
suggesting that exposure to environmental factors capable of eliciting these pathways may be
important in development of sarcoidosis. Polymorphisms in the vitamin D receptor are
intriguing, and have been used in conjunction with an internal phenotype (Vitamin D
deficiency) to suggest the presence of a gene-environment interaction between diet and VDR
for risk of pulmonary tuberculosis among Gujaratis [38]. Vitamin D receptor activity has
multiple potential roles in granulomatous disease, including activation of macrophages,
inhibition of intracellular organisms, and regulation of interferon gamma activity. A strong
negative gene-environment relationship has been demonstrated between one polymorphism
and the presence of 25-Vitamin D deficiency on the risk of tuberculosis [38]. In this example,
the odds ratios for the polymorphism, ff, was 3.6 (p=NS), and for 25-Vitamin D deficiency was
5.7. However, the interaction of both risk factors unexpectedly reduced the odds ratio to 3.1.
The mechanism for his effect is unclear, but it illustrates at least two important aspects of
studying gene-environment interactions. One is the possibility of dismissing the role of a gene
(or biologic pathway) when environmental modifiers are not considered. Second, the
relationships between genes and environment may be complex and unpredictable.
A limitation of using Mendelian randomization approaches for studying gene-environment
interactions in sarcoidosis is the need to better define intermediate phenotypes that relate in a
reasonably specific way to exposures of interest. Humoral or cell-mediated responses to
environmental antigens, such as mycobacterial peptides [39], could be used as an internal
phenotype to search for genetic polymorphisms that interact with exposure to those agents.
However, if the effects of a given polymorphism result in a second (unmeasured) intermediate
phenotype that can also influence the disease but is unrelated to environmental exposure, the
results are difficult to interpret.
Gene-environment interactions in sarcoidosis
Evidence for main effects
Observational data suggesting familial clustering and ethnic susceptibility for sarcoidosis led
early investigators to hypothesize that there might be a genetic predisposition to sarcoidosis.
The inheritance pattern in familial sarcoidosis is complex, suggesting polygenic susceptibility
[40]. More recently, genetic studies of sarcoidosis have demonstrated that specific gene
polymorphisms are involved in both susceptibility to and phenotypic determination of the
disease [41]. Until recently, however, all the genetic analyses in sarcoidosis were restricted to
candidate gene approaches, most of which yielded either negative or weakly significant results
that could not be replicated in other populations.
A model for gene-environment relationships in sarcoidosis may be inferred from another
granulomatous lung disorder, chronic beryllium disease. Chronic beryllium disease is also CD4
+ T-cell mediated, occurs in 2-8% of exposed workers, and is histologically identical to
sarcoidosis [42]. In a seminal observation, Richeldi et al. suggested that carriage of a glutamic
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acid residue at position 69 of the HLA-DPB1 gene conferred susceptibility in exposed workers
[43]. The substitution of glutamate for lysine in this position alters the putative antigen-binding
pocket, favoring beryllium binding [44]. It appears that the major effect of the polymorphism
is to mediate sensitization rather than disease, with other genetic loci likely necessary for
progression to overt disease [45].
Similar to chronic beryllium disease, development of sarcoidosis requires both a susceptible
host and a relevant exposure. Much genetic research to date has focused on the roles of genes
governing the molecules necessary for antigen-specific T-cell stimulation. In this regard,
numerous investigators have described disease associations with HLA polymorphisms,
especially those coding for Class II molecules [3,4]. Predictably, analysis of T-cell receptor
variants has also revealed patterns associated with disease susceptibility or phenotype [46].
However, poor reproducibility has characterized these studies, with substantial inter-
population variability due to population stratification, sampling error, or unsuspected
differences in modifier genes/exposures between populations [2,5]. Epidemiologic
observations have suggested multiple potential etiologic triggers for sarcoidosis, with the
possibility that susceptibility to any putative agent may be a function of the individuals’ genetic
predisposition.
The most suggestive description of gene-environment interactions comes from the recent A
Case Control Etiologic Study of Sarcoidosis (ACCESS) study. The ACCESS study evaluated
epidemiologic risk factors among 706 newly diagnosed patients and a cohort of age-, race-,
and sex-matched control subjects. Several occupational and environmental risk factors were
identified, although their relationship to genetic factors is unknown [47]. The strongest negative
interaction, for smoking (O.R. 0.65), was consistent with prior experience in chronic beryllium
disease and hypersensitivity pneumonitis, where a gene and environment-driven immune
response is negatively influenced by tobacco, a modifier exposure. The data also suggested the
presence of gene-environment interactions by demonstrating that environmental factors
influence the risk of familial sarcoidosis [27]. For siblings of affected Caucasians, the adjusted
familial risk was 20.5 (C.I. 1.8-231.2). Shared environmental exposure, assessed with the
surrogate parameter of time living together prior to the diagnosis of sarcoidosis, conferred
independent risk in this population (O.R. 1.1, C.I. 1.0-1.3) [27]. However, these types of
analyses do not allow consideration of whether the interaction is purely statistical (e.g.
multiplicative) or operates on a biologic level.
Evidence for interaction
The first study to systematically examine gene-environment interactions employed family-
based association analysis to identify HLA-DQB1 susceptibility alleles in 704 individuals from
225 African-American families [3]. Unclear consanguity, suspected by finding non-Mendelian
segregation for a panel of unlinked genomic markers, resulted in exclusion of 8% of the
families. The authors employed a strategy of low-resolution genotyping of DQB1 alleles. Two
alleles, DQB1*02 (protective) and DQB1*06 (susceptibility) deviated significantly from
expected Mendelian frequencies. Fine mapping confirmed the presence of one protective allele,
DQB1*0201, with approximately 50% expected transmission to affected offspring, and one
susceptibility allele, DQB1*0602, transmitted about 20% more often than expected to affected
probands. Sixty-one environmental exposures were assessed with univariable testing in sib
pairs, controlled for age and sex, and modeled for gene-environment interactions if univariate
analysis suggested significance at the p<0.15 level. Testing for gene interaction with ten
exposures revealed the presence of two risk factors, exposure to high humidity in the workplace
for > 1 year and exposure to water damage, that modified the effect of the DQB1*0201 allele;
none of the exposures interacted with DQB1*0602. For DQB1*0201- individuals, exposure to
high humidity increased the chance of developing sarcoidosis (O.R. 1.62, 95% CI 1.03-2.52);
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in contradistinction, the exposure was actually protective in DQB1*0201+ individuals (O.R.
0.47, 95% CI 0.16-1.40). On the other hand, DQB1*0201, a protective allele when examined
for the group, interacted with exposure to water damage in the opposite way. Carriers of the
allele had higher chances of developing sarcoidosis with this exposure than did non-carriers
(O.R. 4.44 vs 1.53). These data represent the strongest published observations to date
documenting a potential true (biologic) gene-environment interaction for sarcoidosis.
Barriers to study of gene-environment interactions in sarcoidosis
A major limitation to study of gene-environment interactions in sarcoidosis is sample size. As
a guideline, the sample size needed to evaluate the effect of a single interaction will be about
four times the number needed for evaluation of either the gene or the exposure [48]. Inadequate
sample size is already an important reason for poor reproducibility of genetic association
studies [49]. In complex diseases like sarcoidosis, modest effect sizes for any given gene will
also necessitate larger study cohorts, unless functional groups of genes can be linked together
for analysis to create functional “haplotypes”. Sample sizes in the hundreds are likely to miss
most effects; the majority of significant findings in such studies are likely to be false positive
[50]. Factors that introduce measurement errors will tend to increase the sample size
requirements, leading to the conclusion that well-done studies in this area will require very
careful planning [51]. Restriction of such studies to strictly-defined clinical phenotypes and
homogenous populations may improve the odds of finding relationships.
Racial admixture may be an additional important factor [52], either tending to mitigate the
chances of finding significant relationships between genes and environment or leading to false
positive findings through unsuspected population stratification. In African-Americans,
admixture may be as high as 22% [53]. This issue is especially relevant in complex polygenic
diseases where the effect size of any given gene is likely to be small. This is not a trivial issue,
since variants of key genes such as HLA and TNF may be influenced in African-Americans
depending on ancestral origin or variable admixture [54]. One potential strategy to deal with
population admixture is to include a panel of putatively non-interacting genes (ancestry
informative markers) that are known to exhibit different allelic frequencies in ancestral
populations [55]. For sarcoidosis, family-based approaches may be the optimal approach to
avoid these concerns.
For assessment of environmental exposures, study design issues will include consideration of
the effects of the intensity, timing and duration of the putative environmental exposure. Most
environmental exposures will require characterization as dichotomous variables, although this
may not be satisfactory from a biologic viewpoint. In addition, recall bias is a substantial
limitation for case-control or family-based studies. Use of a population-based cohort design
reduces this risk substantially, but is not practical for sarcoidosis because of the low prevalence
of the disease and ascertainment biases. Recall bias is especially an issue if development of
the disease alters the individuals’ ascertainment or reporting of an exposure. For example,
individuals with newly diagnosed pulmonary sarcoidosis commonly arrive at the clinic with a
list of occupational agents and a history of noticing “mold” in the basement. Very careful
instrument construction may help alleviate this issue. Another potential solution for some
exposures is the use of serum biomarkers, such as cotinine for tobacco exposure or antibodies
to mycobacterial catalase for tuberculosis [39].
A final issue related to environmental exposure is the rarity of some potentially important
exposures. For example in ACCESS, sample size requirements dictated enrollment of 720 cases
and matched controls to attain 80% power to discover a 2.0 fold relative risk for exposures
present in at least 5% of the population [47]. However, all but one of the environmental factors
associated with disease risk was present in at least 10% of the controls, and approximately half
of the a priori hypotheses could not be tested at the 90% confidence level due to sample size
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limitations. Several factors that had previously been associated with development of
sarcoidosis (naval service, fire-fighting) could not be investigated. The chance of detecting a
true association between environment and disease is thereby lessened, compared to
associations due to widespread environmental exposures.
Conclusion
The study of gene-environment interaction in sarcoidosis is nascent but holds the promise of
dramatically improving our understanding of sarcoidosis. A number of benefits can be
envisioned. Specific pathophysiologic mechanisms will be illuminated, including some that
are not obvious until one considers the interaction of genes and environment. Specific
combinations of genetic susceptibility markers may be linked to individual antigens, allowing
better disease characterization and risk management of populations. It may become evident
that sarcoidosis phenotype is predictable, depending on all three components of the
“trimolecular complex”—the HLA molecule, the T-cell receptor, and the specific antigen
[56]. In the next several decades, when DNA typing is widespread, individuals with genetic
susceptibility may receive counseling about avoidance of specific environmental risks [57].
These advances will require the combined efforts of geneticists, biologists, experts in exposure
characterization, and epidemiologists and will be facilitated by improvements in statistical
modeling of complex interactions. Studies of genetics and epidemiology have yielded
important advances in sarcoidosis; the study of gene-environment interactions promises to be
even more challenging, yet ultimately it should lead to insights that can barely be imagined
now.
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Figure 1.
Proposed model for development of sarcoidosis. Individuals inherit a spectrum of genetic
polymorphisms that may influence susceptibility to disease, but that are only realized in the
context of a relevant exposure. Disease-associated susceptibility genes may influence position
on this matrix differentially, depending on the function of the individual gene product, and on
the influence of gene-gene interactions. The relevance of environmental exposures may be
influenced by their duration, intensity, timing or context. A similar model might also describe
disease phenotype.
Culver et al. Page 12
Clin Dermatol. Author manuscript; available in PMC 2008 May 1.
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
Culver et al. Page 13
Clin Dermatol. Author manuscript; available in PMC 2008 May 1.
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
Figure 2.
Theoretical gene-environment relationships. Panels A and B depict diseases influenced only
by the gene or environmental variable, while Panel C demonstrates an additive relationship for
a dominant mutation “a” with environmental exposure modeled as a continuous variable. Panel
D, a true (biologic) gene-environment interaction, where the effect of the genotype is variably
influenced by the exposure. Modified from [18].
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Figure 3.
Possible gene-environment relationships. Exposure “A” and Genotype “X” represent a gene
or environmental exposure requisite for development of the disease. Modifier genes (T) or
exposures (G) also influence susceptibility or phenotypic determination.
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Figure 4.
Influence of random misclassification error on relative risk estimates. The estimated relative
risk for the outcome depends on the degree actual risk (RR true) and the accuracy of assessing
the exposure of interest [24]. For a hypothetical observer correctly classifying exposure 80%
of the time, a true relative risk of 2.5 would be estimated to be 2.0.
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Figure 5.
Concept of Mendelian randomization. The relationship of the exposure to development of
disease can be estimated by measuring the association of genotype with disease and on
development of an internal phenotype (IP) that is directly related to the disease, thereby
allowing an estimate of the relation between IP and the disease. If the gene can mediate other
internal phenotypes, then no causality can be assigned to the exposure. Modified from [30].
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Table 1
Summary of evidence for environmental and genetic etiologies
Environmental Case clustering Transmission via solid organ or stem cell transplant Case-control association studies (e.g. ACCESS) Analogy to chronic beryllium disease Molecular analysis (micro-organism nucleic acids or proteins)
Genetic Familial aggregation Ethnic susceptibility Case-control association studies Non-parametric studies (e.g. genome scans)
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Table 2
Example of hypothetical calculation for gene-environment interaction for a dichotomous variable (e.g sarcoidosis
risk). The example demonstrates a multiplicative relationship (no interaction) for the gene of interest with
exposure to yttrium, but a suggestion of biologic gene-environment interaction for bohrium.
Exposure Genotype OR for sarcoidosis
Yttrium: N aa 1.0
Y aa 1.5
N ab or bb 4.0
Y ab or bb 6.0
Multiplicative relationship
Bohrium: N aa 1.0
Y aa 1.5
N ab or bb 4.0
Y ab or bb 8.0
Deviates from multiplicative relationship
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Table 3
Consideration for design choices in studies of gene-environment interactions in sarcoidosis
Design
concern family-based case-control cohort
Population stratification bias nil
Potential problem;
minimized by careful design
or genomic control
Generally less than for case-control
studies; minimized by careful design
Recall bias Moderate to high Moderate to high Nil if exposure assessed at inception
Survival bias Low Low Nil if DNA obtained at baseline
Latency bias Possible Low risk with good design Low risk with good design
External validity Least generalizable type Confirmation required inseveral populations
Confirmation required in several
populations
Sample size Achievable Achievable
Difficult except for common
exposures or polymorphisms; would
require pooling of multiple studies
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